CSF1R and neoplasm: Studying the spontaneous neuroblastoma TH-MYCN mouse model, Mao et al. have demonstrated that CSF-1R inhibition efficiently slows tumor progression in tumor-bearing mice and enhances PD-1/PD-L1 antibody therapy [160].